Virtu Financial’s Novartis NVS Stock Holding History

Virtu Financial’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.78M	Buy	+17,757	New	+$2.66M	0.09%	128
2026 Q1	–	Sell	-3,424	Closed	-$472K	–	2095
2025 Q4	$472K	Buy	+3,424	New	+$448K	0.02%	634
2025 Q2	–	Sell	-2,224	Closed	-$248K	–	1871
2025 Q1	$248K	Sell	2,224 -8,051	-78%	-$857K	0.01%	726
2024 Q4	$1M	Buy	10,275 +6,561	+177%	+$700K	0.05%	301
2024 Q3	$427K	Buy	+3,714	New	+$421K	0.02%	513
2023 Q1	–	Sell	-4,428	Closed	-$402K	–	1920
2022 Q4	$402K	Sell	4,428 -12,163	-73%	-$1.02M	0.05%	361
2022 Q3	$1.26M	Buy	16,591 +11,085	+201%	+$919K	0.12%	144
2022 Q2	$465K	Buy	+5,506	New	+$483K	0.04%	410
2021 Q4	–	Sell	-5,142	Closed	-$421K	–	2038
2021 Q3	$421K	Buy	+5,142	New	+$463K	0.04%	551
2021 Q2	–	Sell	-11,028	Closed	-$943K	–	1893
2021 Q1	$943K	Buy	11,028 +8,039	+269%	+$721K	0.07%	274
2020 Q4	$282K	Sell	2,989 -9,897	-77%	-$865K	0.03%	670
2020 Q3	$1.12M	Buy	+12,886	New	+$1.12M	0.19%	106
2019 Q4	–	Sell	-7,582	Closed	-$659K	–	1724
2019 Q3	$659K	Buy	+7,582	New	+$681K	0.05%	407
2019 Q2	–	Sell	-11,864	Closed	-$1.02M	–	1732
2019 Q1	$1.02M	Buy	11,864 +4,781	+67%	+$384K	0.06%	305
2018 Q4	$545K	Buy	7,083 +4,401	+164%	+$343K	0.03%	453
2018 Q3	$207K	Sell	2,682 -2,311	-46%	-$171K	0.01%	1061
2018 Q2	$338K	Buy	+4,993	New	+$345K	0.02%	1068
2017 Q2	–	Sell	-4,057	Closed	-$270K	–	488
2017 Q1	$270K	Sell	4,057 -346	-8%	-$23.1K	0.03%	319
2016 Q4	$287K	Buy	+4,403	New	+$286K	0.03%	360
2016 Q1	–	Sell	-3,700	Closed	-$285K	–	481
2015 Q4	$285K	Buy	+3,700	New	+$294K	0.04%	296
2013 Q3	–	Sell	-49,175	Closed	-$3.12M	–	317
2013 Q2	$3.12M	Buy	+49,175	New	+$3.2M	0.3%	66

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial's NVS Position: Q2 2026 in Review

Virtu Financial opened a new position in Novartis (NVS) in Q2 2026: 17,757 shares worth $2.78M. The stake represents 0.09% of the portfolio and ranks #128 among its holdings. This is a return to the name: Virtu Financial previously reported a position in NVS as recently as Q4 2025.

Virtu Financial first reported a position in NVS in Q2 2013 and has held it in 21 quarters since. The position peaked at $3.12M in Q2 2013. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Virtu Financial held 17,757 shares of Novartis worth $2.78M as of Q2 2026.
Novartis was a new Virtu Financial position in Q2 2026.
Novartis made up 0.09% of Virtu Financial's portfolio in Q2 2026, its #128 holding.
Virtu Financial first reported a position in Novartis in Q2 2013 and has held it in 21 quarters since.
Virtu Financial's Novartis position peaked at $3.12M in Q2 2013.
1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.